Wayfinding Financial LLC Makes New $236,000 Investment in Cardinal Health, Inc. (NYSE:CAH)

Wayfinding Financial LLC acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the fourth quarter, HoldingsChannel reports. The fund acquired 1,995 shares of the company’s stock, valued at approximately $236,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CAH. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Cardinal Health by 35.2% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company’s stock worth $3,871,000 after purchasing an additional 8,471 shares during the last quarter. CHURCHILL MANAGEMENT Corp lifted its position in shares of Cardinal Health by 1.5% during the fourth quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company’s stock valued at $28,435,000 after buying an additional 3,576 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Cardinal Health by 0.7% during the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock valued at $633,298,000 after buying an additional 42,082 shares during the last quarter. Consolidated Planning Corp lifted its position in Cardinal Health by 40.0% during the fourth quarter. Consolidated Planning Corp now owns 8,926 shares of the company’s stock valued at $1,056,000 after acquiring an additional 2,552 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in Cardinal Health by 2.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock valued at $162,976,000 after acquiring an additional 33,388 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $131.80 on Friday. The firm has a fifty day moving average price of $127.35 and a 200 day moving average price of $120.00. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $133.67. The stock has a market cap of $31.84 billion, a PE ratio of 24.59, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.53%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is currently 37.69%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Wells Fargo & Company increased their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and increased their price target for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Mizuho initiated coverage on Cardinal Health in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price target for the company. Morgan Stanley increased their price target on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research note on Friday, January 31st. Finally, JPMorgan Chase & Co. increased their price objective on shares of Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research report on Tuesday, February 4th. Four research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $139.36.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.